Suppr超能文献

使用患者报告的结果来评估医疗保健质量:朝着更好地衡量心血管疾病中的以患者为中心的护理迈进。

Using Patient-Reported Outcomes toAssess Healthcare Quality: Toward Better Measurement of Patient-Centered Care in Cardiovascular Disease.

机构信息

Saint Luke's Mid America Heart Institute, University of Missouri Kansas City,Kansas City, Missouri.

出版信息

Methodist Debakey Cardiovasc J. 2021 Apr 5;17(1):e1-e9. doi: 10.14797/VUWD7697.

Abstract

Patient-reported outcomes (PROs) are elicited directly from patients so they can describe their overall health status, including their symptoms, function, and quality of life. While commonly used as end points in clinical trials, PROs can play an important role in routine clinical care, population health management, and as a means for quantifying the quality of patient care. In this review, we propose that PROs be used to improve patient-centered care in the treatment of cardiovascular diseases given their importance to patients and society and their ability to improve doctor- provider communication. Furthermore, given the current variability in patients' health status across different clinics and the fact that PROs can be improved by titrating therapy, we contend that PROs have a key opportunity to serve as measures of healthcare quality.

摘要

患者报告的结局(PROs)直接从患者那里获得,以便他们能够描述自己的整体健康状况,包括症状、功能和生活质量。虽然常用于临床试验的终点,但 PROs 在常规临床护理、人群健康管理以及量化患者护理质量方面也可以发挥重要作用。在这篇综述中,我们提出鉴于 PROs 对患者和社会的重要性及其改善医患沟通的能力,应将 PROs 用于改善心血管疾病的以患者为中心的治疗。此外,鉴于目前不同诊所的患者健康状况存在差异,并且 PROs 可以通过滴定治疗来改善,我们认为 PROs 有机会成为医疗质量的衡量标准。

相似文献

2
Do cardiology quality measures actually improve patient outcomes?
J Am Heart Assoc. 2014 Feb 7;3(1):e000404. doi: 10.1161/JAHA.113.000404.
3
Value-based Healthcare: Person-centered Measurement: Focusing on the Three C's.
Clin Orthop Relat Res. 2017 Feb;475(2):315-317. doi: 10.1007/s11999-016-5205-5. Epub 2016 Dec 19.
4
Developing a pathway for high-value, patient-centered total joint arthroplasty.
Clin Orthop Relat Res. 2014 May;472(5):1619-35. doi: 10.1007/s11999-013-3398-4. Epub 2013 Dec 3.
5
Paying for Performance Improvement in Quality and Outcomes of Cardiovascular Care: Challenges and Prospects.
Methodist Debakey Cardiovasc J. 2020 Jul-Sep;16(3):225-231. doi: 10.14797/mdcj-16-3-225.
6
Quality and Value of Health Care in the Veterans Health Administration: A Qualitative Study.
J Am Heart Assoc. 2019 May 7;8(9):e011672. doi: 10.1161/JAHA.118.011672.
7
Cardiologist Participation in Accountable Care Organizations and Changes in Spending and Quality for Medicare Patients With Cardiovascular Disease.
Circ Cardiovasc Qual Outcomes. 2019 Sep;12(9):e005438. doi: 10.1161/CIRCOUTCOMES.118.005438. Epub 2019 Sep 16.
8
Improving outcomes for ESRD patients: shifting the quality paradigm.
Clin J Am Soc Nephrol. 2014 Feb;9(2):430-4. doi: 10.2215/CJN.05980613. Epub 2013 Nov 7.
9
The Role of National Registries in Improving Quality of Care and Outcomes for Cardiovascular Disease.
Methodist Debakey Cardiovasc J. 2020 Jul-Sep;16(3):205-211. doi: 10.14797/mdcj-16-3-205.
10
Quality Measures for Dialysis: Time for a Balanced Scorecard.
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):363-8. doi: 10.2215/CJN.06010615. Epub 2015 Aug 27.

引用本文的文献

1
Clinical Impact of Routine Assessment of Patient-Reported Health Status in Heart Failure Clinic: The PRO-HF Trial.
Circulation. 2024 May 28;149(22):1717-1728. doi: 10.1161/CIRCULATIONAHA.124.069624. Epub 2024 Apr 7.
2
Identifying performance indicators to measure overall performance of telephone triage - a scoping review.
Scand J Prim Health Care. 2024 Mar;42(1):38-50. doi: 10.1080/02813432.2023.2283188. Epub 2024 Feb 7.
4
Epoxylipids and soluble epoxide hydrolase in heart diseases.
Biochem Pharmacol. 2022 Jan;195:114866. doi: 10.1016/j.bcp.2021.114866. Epub 2021 Dec 2.

本文引用的文献

3
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
N Engl J Med. 2020 Oct 8;383(15):1413-1424. doi: 10.1056/NEJMoa2022190. Epub 2020 Aug 28.
5
Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry.
JACC Heart Fail. 2020 Jun;8(6):469-480. doi: 10.1016/j.jchf.2019.12.015. Epub 2020 May 6.
6
Initial Invasive or Conservative Strategy for Stable Coronary Disease.
N Engl J Med. 2020 Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30.
7
Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
N Engl J Med. 2020 Apr 9;382(15):1408-1419. doi: 10.1056/NEJMoa1916370. Epub 2020 Mar 30.
8
Quality of life predicting long-term outcomes in cardiac resynchronization therapy patients.
Europace. 2019 Dec 1;21(12):1865-1875. doi: 10.1093/europace/euz262.
9
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19.
10
Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF.
JACC Heart Fail. 2019 Jul;7(7):615-625. doi: 10.1016/j.jchf.2019.03.020. Epub 2019 Jun 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验